Paul Glavine
Founder presso CYBIN INC.
Patrimonio netto: 5 M $ in data 31/03/2024
Profilo
Paul Glavine was the founder of Cybin Corp.
(founded in 2019) where he held the title of Chief Executive Officer & Director.
He is also the founder of Global Canna Labs Ltd.
(founded in 2015) where he holds the title of Managing Director.
Additionally, Mr. Glavine is the founder of Cybin, Inc. (founded in 2016) where he holds the title of Director & Chief Growth Officer.
Mr. Glavine is also the founder of Truverra, Inc. Mr. Glavine's current job(s) include being a Director at Adelia Therapeutics, Inc. and a Director, Head-Finance & Investment at Ownner, Inc.Mr. Glavine's former job includes being the Chief Operating Officer & Director at Clarmin Explorations, Inc.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
CYBIN, INC.
2.74% | 20/03/2024 | 11 242 407 ( 2.74% ) | 5 M $ | 31/03/2024 |
Posizioni attive di Paul Glavine
| Società | Posizione | Inizio |
|---|---|---|
| CYBIN INC. | Founder | 13/10/2016 |
| Global Canna Labs Ltd. | Founder | 01/01/2015 |
Adelia Therapeutics, Inc.
 Adelia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adelia Therapeutics, Inc. operates as an biopharmaceutical company. The company was founded by Alex Nivorozhkin and Brett J. Greene in 2020 and is headquartered in Fitchburg, MA. | Director/Board Member | - |
| Ownner, Inc. | Director of Finance/CFO | - |
Precedenti posizioni note di Paul Glavine
| Società | Posizione | Fine |
|---|---|---|
| CLARMIN EXPLORATIONS INC. | Chief Operating Officer | - |
Truverra, Inc.
 Truverra, Inc. Pharmaceuticals: OtherHealth Technology Truverra, Inc. engages in development, production, and marketing of hemp and cannabis derived medicinal products. The company was founded by Brad Stott and is headquartered in Toronto, Canada. | Founder | - |
Cybin Corp.
 Cybin Corp. Medical DistributorsDistribution Services Cybin Corp. engages in psychedelic drug development, unique delivery mechanisms, improved novel compounds and protocols that target psychiatric and neurological conditions. The company was founded by Paul Glavine, Eric So, and John Kanakis and is headquartered in Toronto, Canada. | Chief Executive Officer | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CYBIN INC. | Health Technology |
| Aziende private | 6 |
|---|---|
Clarmin Explorations, Inc.
 Clarmin Explorations, Inc. Precious MetalsNon-Energy Minerals Clarmin Explorations, Inc. is an exploration company. The firm engages in the exploration and development of mineral properties. It holds interest in the Arlington property. The company was founded on October 13, 2016 and is headquartered in Toronto, Canada. | Non-Energy Minerals |
Truverra, Inc.
Truverra, Inc. Pharmaceuticals: OtherHealth Technology Truverra, Inc. engages in development, production, and marketing of hemp and cannabis derived medicinal products. The company was founded by Brad Stott and is headquartered in Toronto, Canada. | Health Technology |
Cybin Corp.
Cybin Corp. Medical DistributorsDistribution Services Cybin Corp. engages in psychedelic drug development, unique delivery mechanisms, improved novel compounds and protocols that target psychiatric and neurological conditions. The company was founded by Paul Glavine, Eric So, and John Kanakis and is headquartered in Toronto, Canada. | Distribution Services |
| Global Canna Labs Ltd. | |
Adelia Therapeutics, Inc.
Adelia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adelia Therapeutics, Inc. operates as an biopharmaceutical company. The company was founded by Alex Nivorozhkin and Brett J. Greene in 2020 and is headquartered in Fitchburg, MA. | Health Technology |
| Ownner, Inc. |
- Borsa valori
- Insiders
- Paul Glavine
